Back to top

Biodexa Pharmaceuticals announces 1-for-10 reverse ADR split to regain Nasdaq compliance

Biodexa Pharmaceuticals announces 1-for-10 reverse ADR split to regain Nasdaq compliance

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX)